Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.418
-0.024 (-5.35%)
At close: Dec 20, 2024, 4:00 PM
0.426
+0.009 (2.03%)
After-hours: Dec 20, 2024, 5:06 PM EST
Carisma Therapeutics Stock Forecast
CARM's stock price has decreased by -85.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CARM stock have an average target of 4.57, with a low estimate of 0.70 and a high estimate of 12. The average target predicts an increase of 993.56% from the current stock price of 0.42.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CARM stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 1 |
| Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 16, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,771.50% | Dec 12, 2024 |
| Baird | Baird | Buy → Hold Downgrades $10 → $1 | Buy → Hold | Downgrades | $10 → $1 | +139.29% | Dec 12, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $4 → $0.7 | Buy → Hold | Downgrades | $4 → $0.7 | +67.50% | Dec 11, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
Financial Forecast
Revenue This Year
21.83M
from 14.92M
Increased by 46.34%
Revenue Next Year
20.73M
from 21.83M
Decreased by -5.06%
EPS This Year
-1.22
from -2.59
EPS Next Year
-0.63
from -1.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 25.2M | 26.3M | 21.0M | |||
| Avg | 21.8M | 20.7M | 10.2M | |||
| Low | 19.0M | 14.3M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 68.9% | 20.2% | 1.3% | |||
| Avg | 46.3% | -5.1% | -50.8% | |||
| Low | 27.2% | -34.5% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.18 | -0.30 | -0.43 | |||
| Avg | -1.22 | -0.63 | -0.51 | |||
| Low | -1.29 | -0.98 | -0.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.